Optimisation of DNA vaccines for thé prophylaxis and modulation of herpes simplex virus infections

Expert Opinion on Biological Therapy

Volumn 1, Issue 2, 2001, Pages 213-225

  Eo, Seong Kug ^a   Pack, Christopher ^a   Kumaraguru, Udayasankar ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

CPG motifs; DNA vaccines; Herpes simplex virus; Immunomodulation; Mucosal immunity; Prime boost vaccination

Indexed keywords

CHEMOKINE; CYTOKINE; DNA VACCINE; IMMUNOLOGICAL ADJUVANT;

ANIMAL; ANIMAL MODEL; CPG ISLAND; GENETICS; HERPES SIMPLEX; HUMAN; IMMUNOLOGY; MUCOSAL IMMUNITY; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; CHEMOKINES; CPG ISLANDS; CYTOKINES; HERPES SIMPLEX; HUMAN; IMMUNITY, MUCOSAL; MODELS, ANIMAL; VACCINES, DNA;

EID: 0035292550     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.1.2.213     Document Type: Article

References (82)

1. LIESEGANG TJ, MELTON IJ, DALY PJ, ILSTRUP DM: Epidermiology of ocular herpes simplex virus: Incidence in Rochester, Minn, 1950 through 1982.. Arch. Optbalmol. (1989) 107:1155-1159.
2. Committee on issues and priorities for new vaccine development. Appendix I: prospects for immunizing against herpes simplex viruses 1 and 2. In: New Vaccine Development: Establishing Priorities. National Academy Press, Washington DC, USA (1985): 1105-1111.
3. BERNSTEIN DI, STANBERRY LR: Herpes simplex virus vaccines. Vaccine (1999) 17:1681-1689.
4. COX GJM, ZAMB TJ, BABIUK LA: Bovine herpes virus I: Immune responses in mice and cattle injected -with plasmld DNA.J. Viml. (1993) 67:5664-5667.
5. KRIESEL JD, SPRUANCE SL, DAYNES RA, ARANEO BA: Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus Type 2 disease. J. Infect. Dis. (1996) 173:536-541.
6. MANICKAN E, ROUSE RJD, YU Z, WIRE WS, ROUSE BT: Genetic immunization against herpes simplex virus: Protection is mediated by CD4+ T-lymphocytes. J. Immunol. (1995) 155:259-265.
7. BOURNE N, STANBERRY LR, BERNSTEIN DI, LEW D: DNA immunization against experimental genital herpes simplex virus infection.J. Infect. Dis. (1996) 173:800-807.
8. MANICKAN E, YU Z, ROUSE RJD, WIRE WS, ROUSE BT: Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP27. Viral Immunol. (1995) 8:53-61.
9. MANICKAN E, FRANCOTTE M, KUKUN NA, DEWERCHIN M, MOLITOR C, GHEYSEN D et al: Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Thl T-cells. / Virol. (1995) 69:4711-4716.
10. BERNSTEIN DI, TEPE ER, MESTER JC, ARNOLD RL, STANBERRY LR, HIGGINS TJ: Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus. Vaccine (.1999) 17:1964-1969.
11. MESTER JC, TWOMEY TA, TEPE ET, BERNSTEIN DI: Immunity induced by DNA immunization with herpes simplex virus Type 2 gh/coproteins B and C. Vaccine (1999) 18:875-883-
12. MCCLEMENTS WL, ARMSTRONG ME, KEYS RD, LIU MA: Immunization with DNA vaccine encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. A'atl. Acad. Set. USA (1996) 93:11414-11420.
13. SUTER M, LEW AM, GROB P, ADEMA GJ, ACKERMANN M, SHORTMAN K, FRAEFEL C: BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc. A'atl. Acad. Sei. USA (1999) 96:12697-12702.
14. PACHUK CJ, ARNOLD R, HEROLD K, CICCARELLI RB, HIGGINS TJ: Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice. Citrr. Top. Mtcrobiol. Immunol. (1998) 226:79-89.
15. GOULD-FOGERITE S, MANNING RJ: Mucosal and systemic immunization using cochleate and liposome vaccines.J. Liposome Res. (1996) 2:357-379.
16. MANNING RJ, CANKI M, FEKETEOVA E, SCOLPINO AJ, WANG Z, ZHANG F et al: Targeting immune response induction with cochleate and liposome-based vaccines. Adv. Drug Dcliv. Rev. (1998) 32:273-287.
17. ZARIF L, MANNING RJ: Cochleates. Lipid-based vehicles for gene delivery-concept, achievements and future development. Adv. Exp. Med. Biol. (2000) 465:83-93.
18. KADOWAKI S-E, CHEN Z, ASANUMA H, AIZWA C, KURATA T, TAMURA SI: Protection against influenza virus infection in mice immunized by administration of hemagghitinin-expressing DNAs with electroporation. Vaccine (2000) 18:2779-2788.
19. WIDERA G, AUSTIN M, RABUSSAY D, GOLDBECK C, BARNETT SW, CHEN M et al: Increased DNA vaccine delivery and immuiiogeiiicity by electroporation In vivo. J. . Immunol (2000) 164:4635-4640.
20. CONDON C, WATKINS SC, CELLUZZI CM, THOMPSON K, FALO LD: DNA based immunization by In vivo transfection of dendritic cells. Nature Med. (1996) 2:1122-1128.
21. DOE B, SELBYM, BARNETT S, BAENZIGERJ, WALKER CM: Induction of cytotoxic T-rymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow derived cells. Proc. Natl. Acad. Sei. USA (1996) 93:8578-8583.
22. ZAROZINSKI CC, FYNAN EF, SELIN LK, ROBINSON HL, WELSH RM: Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an Internal virion protein, J. Immunol. (1995) 154:4010-4017.
23. CODON C, WATKINS SC, CELLUZZI CM, THOMPSON K, FALO LD Jr: DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. (1996) 2:1122-1128.
24. ROUSE RJD, NAIR SK, LYDY SL, BOWEN JC, ROUSE BT: Induction of in vitro primary cytotoxic T-lymphocytes responses with DNA encoding herpes simplex virus proteins. J. Vriol. (1994) 68:5685-5689.
25. NLANICKAN E, KANANGAT S, ROUSE RJ, YU Z, ROUSE BT: Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells.J. Leukoc. Biol. (1997) 61:125-132.
26. AGGARWAL A, KUMAR S, RICHARD J, HONE D, GROSS M, SADOFF J: Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells.J. Exp. Med. (1990) 172:1083-1090.
27. CATIC A, DIETRICH G, GENTSCHEV I, GOEBEL W, KAUFMANN SH, HESS J: Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages. Microbes Infect. (1999) 1:113-121.
28. DARJI A, GUZMAN CA, GERSTEL B, WACHHOLZ P, TLMMIS KN, WEHLAND J et al.: Oral somatic transgene vaccination using attenuated S. typbimurlum. Cell (1997) 91:765-775.
29. DUBENSKY TW, DRIVER DA, POLO JM, BELLI BA, LATHAM EM, IBANEZ CE et al: Sindbis virus DNA-based expression vectors: Utility for in vitro and In vivo gene transfer. J. Virol. (1996) 70:508-519.
30. HARIHARAN MJ, DRIVER DA, TOWNSEND K, BRUMM D, POLO JM, BELLI BA et al.: DNA immunization against herpes simplex virus: Enhanced efficacy using a sindbis virus-based vector. J. Virol. (1998) 72:950-958.
31. MESTER J, MILLIGAN GN, BERSTEIN DI: The immunobiology of herpes simplex virus, In: Genital and neonatal herpes. Stanberry LR (Ed.), John Wiley and Sons. Ltd. (1996): 49-91.
32. KUKLIN NA, DAHESHIA M, KAREM K, MANICKAN E, ROUSE BT: Induction of mucosal immunity against herpes simplex virus by DNA immunization. J. Virol. (1997) 71:3138-3145.
33. KAREM K, BOWEN J, KUKLIN N, ROUSE BT: Protective immunity against herpes simplex virus (HSV) Type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. J. Gen. Virol. (1997) 78:427-434.
34. YU Z, KAREM KL, KANANGAT S, MANICKAN E, ROUSE BT: Protection by minigenes: a novel approach of DNA vaccines. Vaccine (1998) 16:1660-1667.
35. XIANG Z, ERTL HC: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmid expressing cytokines. Immunity (V)9-i) 2:129-135.
36. AHLERS JD, DUNLOP N, ALLING DW, NARA PL, BERZOFSKY JA: Cytokine-ln-adjuvant steering of the immune response phenotype to HIV-1 vaccine cinstructs: granulocyte-macrophage colonystimulating factor and TNF-cc synergize with IL-12 to chance induction of cytotoxic T lymphocytes. J. Immunol. (1997) 158:3947-3958.
37. BELYAKOV IM, AHLERS JD, CLEMENTS JD, STROBER W, BERZOFSKY JA: Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL. J. Immunol. (2000) 165:6454-6462.
38. OKADA E, SASAKI S, ISHH N, AOKI I, YASUDA T, NISHIOKA K et al: Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposome induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol (1997) 159:3638-3647.
39. XIN KQ, HAMAJIMA K, SASAKI S, TSUJI T, WATABE S, OKADA E et al: IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine (1999) 17:858-866.
40. SIN JI, KLM JI, UGEN KE, CICCARELLI RB, HIGGINS TJ, WEINER DB: Enhancement of protective humoral (Th2) and cell-mediated (Thl) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Etir. J. Immunol. (1998) 28:3530-3540.
41. SIN JI, KIM JI, BOYER JD, CICCARELLI RB, HIGGINS TJ, WEINER DB: In vivo modulation of vaccine-Induced immune responses toward a Thl phenotype increase potency and vaccine effectiveness in a herpes simplex virus Type 2 mouse model. J. Virol. (1999) 73:501-509.
42. SIN JI, KLM JI, ARNOLD RL, SHROFF KE, McCALLUS D, PACHUK C et al.: IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: II-12 enhances Thl-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. (1999) 162:2912-2921.
43. CHUN S, DAHESHIA M, KUKLIN NA, ROUSE BT: Modulation of viral immunoinflamniatory responses with cytoklne DNA-administered by different routes. J. Virol. (1998) 72:5545-5551.
44. KUKLIN NA, DAHESHIA M, CHUN S, ROUSE BT: Immunomodulation by mucosal gene transfer using TGF-β DNA. J. Clin. Invest. (1998) 102:438-444.
45. DAHESHIA M, KUKLIN N, KANANGAT S, MANICKAN E, ROUSE BT: Suppression of ongoing ocular inflammatory disease by topical administration of p las mid DMA encoding IL-10. J. Immunol. (1997) 159:1945-1952.
46. IWASAKI A, STIERNHOLM BJ, CHAN AK, BERNSTEIN NL, BARBER BH: Enhanced CTL responses mediated by plasmid DNA immunogens encoding co-stimulatory molecules and cytokines. J. Immunol. (1997) 158:459M601.
47. PASQUINI S, XIANG Z, WANG Y, HE Z, DENG H, BLASZCZYK-THURIN M et al.: Cytokines and co-stimulatory molecules as genetic adjuvants. Immunol CellBlol. (1997) 75:397-401.
48. TSUJIT, HAMAJIMA K, ISHI N, AOKI I, FUKUSHIMA J, XIN KQ et al: Immunomodulatoiy effects of a plasmid expressing B7-2 on human immunodeficiency' virus1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. (1997) 27:782-787.
49. SIN JI, KLM J, DANG K, LEE D, PATCHUK C, SATISH-CHANDRAN C, WEINER DB: LFA-1 plasmid DNA enhances Ag-specific humoral- and cellular mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells In protection. Cell Immunol. (2000) 203:19-28.
50. MENDOZA RB, CANTWELL MJ, KIPPS TJ: Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. / Immunol. (1997) 159:5777-5781.
51. BOYER JD, KIM J, UGEN K, COHEN AD, AHN L, SCHUMANN K et al: HIV-1 DNA vaccines and chemokines. Vaccine (1999) 2:S53-S64.
52. SIN JI, KIM JJ, PACHUK C, SATISHCHANDRAN C, WEINER DB: DNA vaccines encoding interIeukin-8 and RANTES enhance antigen-specific Thl-type CD4+ T cell-mediated protective immunity against herpes simplex virus Type 2 in vivo. J. Virol (2000) 74:11173-11180.
53. LU Y, XIN KQ, HAMAJIMA K, TSIJIT, AOKI I, YANG J et al.: Macrophage inflammatory protein-1 alpha (MlP-la) expression plasmid enhances DNA vaccine-Induced immune response against HIV-1. Clin. Exp. Immiinol. (1999) 115:335-341.
54. EO SK, LEE S, CHUN S, ROUSE BT: Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.J. Virol. (2001) In press.
55. EO SK, LEE S, KUMARAGURU U, ROUSE BT: Immunopotentiating of DNA vaccine against herpes simplex virus via co-delivery of palsmid DNA expressing CCR7 ligands. (Submitted).
56. RODRIGUEZ F, ZHANG J, WHITTON JL: DNA immunization: ubiquitinatlon of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. (1997) 71:8497-6503.
57. KILNMAN DM, YAMSHCHIKOV G, ISHIGATSUBO Y: Contribution of CpG motifs to the immunogenicity of DNA vaccines.J. Immunol. (1997) 158:3635-3039.
58. LIU DW, TSAO YP, KUNG JT, DING YA, SYTWU HK, XIAO X et al.-. Recombinant adeno-associated virus expressing human papillomavirus Type 16 E7 peptide DNA fused -with heat shock protein DNA as a potential vaccine for cervical cancer. J. Virol. (2000) 74:2888-2894.
59. FLO J, TISMINETZKY S, BARALLE F: Modulation of the immune response to DNA vaccine by co-delivery of co-stimulatory molecules. Immunology (2000) 100:259-269.
60. MANICKAN E, KAREM KL, ROUSE BT: DNA vacclnes-A modern gimmick or a boon to vaccinology? Oil. Rev. Immunol. (1997) 17:139-154.
61. KRIEG MI, YI AK, A1ATSON S et al: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 374:546-549.
62. STAGEY KJ, SWEET MJ, HUME DA: Macrophage ingest and are activated by bacterial DNA. J. Immunol. (1996) 157:2116-2122.
63. JAKOB T, WALKER PS, KRIEG AM, UDEY MC, VOGEL JC: Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Thl responses by immunostimulatory DNA. J. Immunol. (1998) 161:3042-3049.
64. COWDERY JS, CHACE JH, YI AK, KRIEG AM: Bacterial DNA induces NK cells to produce IFN-_ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. (1996) 156:4570-4575.
65. BENDIGS S, SALZER U, LIPFORD GB, WAGNER H, HEEG K: CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur.J. Immunol. (1999) 29:1209-1218.
66. GALLICHAN WS, WOOLSTENCROFT RN, GAURASCI T, McCLUSKIE MJ, DAVIS HL, ROSENTHAL KL: Mucosal immunization -with CpG ODN Induces sigificant IgA and protection against HSV-2 in the genital tract. Proceedings of the 2$h International Herpcsvinis Workshop (2000) 5-59.
67. CHU RS, TARGONI OS, KRIEG AM, LEHMANN PV, HARDING CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Thl) immunity.J. Exp. Med. (1997) 186:1623-1631.
68. KRIEG AM, WU T, WEERATNA R, EFLER S.\I, LOVE-HOMAN L, YANG L et al.: Sequence motüs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sei. USA (1998) 95:12631-12636.
69. RAMSAY AJ, LEON'G KH, RAMSHAW IA: DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol. Cell Btol. (1997) 75:382-388.
70. RAMSHAW IA, RAMSAY AJ: The prime-boost strategy: exciting prospects for improves vaccination. Immu noJ. Today (2000) 21:163-165.
71. SIN JI, BAGARAZZI M, PACHUK C, WEINER DB: DNA-priming-protein boosting enhances both antigen-specific antibody and Thl-type cellular immune responses in a mutine herpes simplex virus-2 gD vaccine model. DNA Cell Biol. (1999) 18:771-779.
72. LEE S, CHUN S, EO SK, ROUSE BT: Immunization via the gastric mucosa - an approach to boost and modulate immunity with DNA vaccine. Crtl. Eur. J. Immunol. (2000) 25.
73. CHUN S, DAHESHIA M, LEE S, EO SK, ROUSE BT: Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding JL-W.J. Immunol. (1999) 163:2393-2402.
74. CASARES S, INABA K, BRUMEANU TO, STEIMAN RM, BONA CA: Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. (1997) 186:1481-1486.
75. BOULOC A, WALKER P, GRIVEL JC, VOGEL JC, KATZ SI: Immunization through dermal delivery of protein-encoding DNA: a role for migratory dendritic cells. Eur.J. Immunol. (1999) 29:4-46-454.
76. DOE B, SELBY M, BARNETT S, BAENZIGER J, WALKER CM: Induction of cytotoxic T lymphocytes by Intramuscular Immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc, Nail. Acad. Sei. USA (1996) 93:8578-8583.
77. WITMER-PACK MD, CROWLEY MT, INABA K, STEINMAN RM: Macrophage, but not dendritic cells, accumulate colloidal carbon following administration hi situ. J. Cell Set. (1993) 105:965-973.
78. BEVAN MJ: Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. (1995) 182:639-641.
79. FU TM, ULMER JB, CAULFIELD MJ, DECK RR, FRIEDMAN A, WANG S et al.: Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigenpresenting cells and evidence for antigen transfer from myocytes. Mol. Mod. (1997) 3:362-371.
80. CORR M, VON-DAMM A, LEE DJ, T1GHE H: In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol. (1999) 163:4721-4727.
81. PORGADOR A, IRVINE KR, IWASAKI A, BARBER BH, RESTIFO NP, GERMAIN RN: Predominant role for directly transfected dendritic cells hi antigen presentation to CD8+ T cells after gene gun immunization.J. Exp. Med. 188:1075-1083.
82. KUMARAGURU U, ROUSE RJ, NAIR SK, BRUCE BD, ROUSE BT: Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization. J. Immunol. (2000) 165:750-759.